🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
B7451037 is a randomized, double-blind, placebo-controlled, parallel-group,...
Status
Completed
Location
California Dermatology & Clinical Research Institute
Start Date
2020-06-18
Trial ID
NCT03915496
Treatments Being Tested
B7451014 is a Phase 3 study to investigate PF-04965842 in patients aged 12 ...
Status
Completed
Location
Total Skin and Beauty Dermatology Center, PC
Start Date
2018-06-11
Trial ID
NCT03627767
Treatments Being Tested
This is a Phase 1, randomized, 2 way crossover, open-label study of the eff...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2018-09-26
Trial ID
NCT03662516
Treatments Being Tested
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical...
Status
Completed
Location
Total Skin and Beauty Dermatology Center, PC
Start Date
2018-03-08
Trial ID
NCT03422822
B7451013 is a Phase 3 study to evaluate PF-04965842 in patients aged 12 yea...
Status
Completed
Location
Emmaus Research Center, Inc.
Start Date
2018-06-29
Trial ID
NCT03575871
Treatments Being Tested
The purpose of this study is to assess the pharmacokinetics, safety and tol...
Status
Completed
Location
Beijing Hospital Sub-Center of Beijing Hospital Clinical Trial & Research Center
Start Date
2019-10-14
Trial ID
NCT04099563
Treatments Being Tested
This is a Phase 1, randomized, 2-way crossover, multiple dose, open label s...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2018-07-03
Trial ID
NCT03647670
Treatments Being Tested
This is a Phase 1 open label, 2 period, single fixed sequence study designe...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2018-09-13
Trial ID
NCT03637790
Treatments Being Tested